Downregulation  ||| S:0 E:15 ||| NNP
of  ||| S:15 E:18 ||| IN
fatty  ||| S:18 E:24 ||| JJ
acid  ||| S:24 E:29 ||| NN
synthase  ||| S:29 E:38 ||| VBZ
complex  ||| S:38 E:46 ||| JJ
suppresses  ||| S:46 E:57 ||| JJ
cell  ||| S:57 E:62 ||| NN
migration  ||| S:62 E:72 ||| NN
by  ||| S:72 E:75 ||| IN
targeting  ||| S:75 E:85 ||| VBG
phospho‑AKT  ||| S:85 E:97 ||| NN
in  ||| S:97 E:100 ||| IN
bladder  ||| S:100 E:108 ||| JJ
cancer  ||| S:108 E:115 ||| NN
The  ||| S:115 E:119 ||| DT
aim  ||| S:119 E:123 ||| NN
of  ||| S:123 E:126 ||| IN
the  ||| S:126 E:130 ||| DT
present  ||| S:130 E:138 ||| JJ
study  ||| S:138 E:144 ||| NN
was  ||| S:144 E:148 ||| VBD
to  ||| S:148 E:151 ||| TO
investigate  ||| S:151 E:163 ||| VB
the  ||| S:163 E:167 ||| DT
effect  ||| S:167 E:174 ||| NN
of  ||| S:174 E:177 ||| IN
fatty  ||| S:177 E:183 ||| FW
acid  ||| S:183 E:188 ||| FW
synthase  ||| S:188 E:197 ||| FW
complex  ||| S:197 E:205 ||| FW
( ||| S:205 E:206 ||| -LRB-
FASN ||| S:206 E:210 ||| NNP
)  ||| S:210 E:212 ||| -RRB-
on  ||| S:212 E:215 ||| IN
the  ||| S:215 E:219 ||| DT
migration  ||| S:219 E:229 ||| JJ
capacity  ||| S:229 E:238 ||| NN
of  ||| S:238 E:241 ||| IN
bladder  ||| S:241 E:249 ||| JJ
transitional  ||| S:249 E:262 ||| JJ
cell  ||| S:262 E:267 ||| NN
carcinoma  ||| S:267 E:277 ||| NNS
( ||| S:277 E:278 ||| -LRB-
BTCC ||| S:278 E:282 ||| NNP
)  ||| S:282 E:284 ||| -RRB-
cells  ||| S:284 E:290 ||| NNS
and  ||| S:290 E:294 ||| CC
the  ||| S:294 E:298 ||| DT
involvement  ||| S:298 E:310 ||| NN
of  ||| S:310 E:313 ||| IN
matrix  ||| S:313 E:320 ||| CD
metalloproteinase‑9  ||| S:320 E:340 ||| CD
( ||| S:340 E:341 ||| -LRB-
MMP‑9 ||| S:341 E:346 ||| NNP
)  ||| S:346 E:348 ||| -RRB-
via  ||| S:348 E:352 ||| IN
targeting  ||| S:352 E:362 ||| VBG
of  ||| S:362 E:365 ||| IN
phospho‑AKT  ||| S:365 E:377 ||| NNP
( ||| S:377 E:378 ||| -LRB-
p‑AKT ||| S:378 E:383 ||| NNP
) ||| S:383 E:384 ||| -RRB-
.  ||| S:384 E:386 ||| .
FASN‑specific  ||| S:386 E:400 ||| NNP
small‑interfering  ||| S:400 E:418 ||| NNP
RNA  ||| S:418 E:422 ||| NNP
( ||| S:422 E:423 ||| -LRB-
FASN‑siRNA ||| S:423 E:433 ||| NNP
)  ||| S:433 E:435 ||| -RRB-
was  ||| S:435 E:439 ||| VBD
used  ||| S:439 E:444 ||| VBN
to  ||| S:444 E:447 ||| TO
inhibit  ||| S:447 E:455 ||| VB
FASN  ||| S:455 E:460 ||| JJ
gene  ||| S:460 E:465 ||| NN
expression  ||| S:465 E:476 ||| NN
in  ||| S:476 E:479 ||| IN
the  ||| S:479 E:483 ||| DT
5637  ||| S:483 E:488 ||| CD
and  ||| S:488 E:492 ||| CC
253J  ||| S:492 E:497 ||| NNP
BTCC  ||| S:497 E:502 ||| NNP
cell  ||| S:502 E:507 ||| NN
lines ||| S:507 E:512 ||| NNS
.  ||| S:512 E:514 ||| .
The  ||| S:514 E:518 ||| DT
knockdown  ||| S:518 E:528 ||| JJ
efficiency  ||| S:528 E:539 ||| NN
of  ||| S:539 E:542 ||| IN
FAM‑conjugated  ||| S:542 E:557 ||| NNP
FASN‑siRNA  ||| S:557 E:568 ||| NNP
was  ||| S:568 E:572 ||| VBD
confirmed  ||| S:572 E:582 ||| VBN
by  ||| S:582 E:585 ||| IN
fluorescence  ||| S:585 E:598 ||| JJ
microscopy ||| S:598 E:608 ||| NN
.  ||| S:608 E:610 ||| .
The  ||| S:610 E:614 ||| DT
migratory  ||| S:614 E:624 ||| JJ
abilities  ||| S:624 E:634 ||| NNS
of  ||| S:634 E:637 ||| IN
BTCC  ||| S:637 E:642 ||| NNP
cells  ||| S:642 E:648 ||| NNS
were  ||| S:648 E:653 ||| VBD
assessed  ||| S:653 E:662 ||| VBN
using  ||| S:662 E:668 ||| VBG
a  ||| S:668 E:670 ||| DT
Transwell  ||| S:670 E:680 ||| JJ
assay ||| S:680 E:685 ||| NN
.  ||| S:685 E:687 ||| .
Furthermore ||| S:687 E:698 ||| RB
,  ||| S:698 E:700 ||| ,
protein  ||| S:700 E:708 ||| NN
and  ||| S:708 E:712 ||| CC
mRNA  ||| S:712 E:717 ||| JJ
expression  ||| S:717 E:728 ||| NN
of  ||| S:728 E:731 ||| IN
FASN ||| S:731 E:735 ||| NNP
,  ||| S:735 E:737 ||| ,
p‑AKT ||| S:737 E:742 ||| NNP
,  ||| S:742 E:744 ||| ,
AKT ||| S:744 E:747 ||| NNP
,  ||| S:747 E:749 ||| ,
and  ||| S:749 E:753 ||| CC
migration‑associated  ||| S:753 E:774 ||| CD
protein  ||| S:774 E:782 ||| NN
MMP‑9  ||| S:782 E:788 ||| NN
were  ||| S:788 E:793 ||| VBD
detected  ||| S:793 E:802 ||| VBN
by  ||| S:802 E:805 ||| IN
western  ||| S:805 E:813 ||| JJ
blot  ||| S:813 E:818 ||| JJ
analysis ||| S:818 E:826 ||| NN
.  ||| S:826 E:828 ||| .
Treatment  ||| S:828 E:838 ||| NN
with  ||| S:838 E:843 ||| IN
FASN  ||| S:843 E:848 ||| NNP
inhibitor  ||| S:848 E:858 ||| VBD
Cer  ||| S:858 E:862 ||| NNP
and  ||| S:862 E:866 ||| CC
FASN‑siRNA  ||| S:866 E:877 ||| NNP
decreased  ||| S:877 E:887 ||| VBD
the  ||| S:887 E:891 ||| DT
migratory  ||| S:891 E:901 ||| JJ
capacity  ||| S:901 E:910 ||| NN
of  ||| S:910 E:913 ||| IN
bladder  ||| S:913 E:921 ||| JJ
cancer  ||| S:921 E:928 ||| NN
cells  ||| S:928 E:934 ||| NNS
and  ||| S:934 E:938 ||| CC
reduced  ||| S:938 E:946 ||| VBD
the  ||| S:946 E:950 ||| DT
levels  ||| S:950 E:957 ||| NNS
of  ||| S:957 E:960 ||| IN
p‑AKT  ||| S:960 E:966 ||| CD
as  ||| S:966 E:969 ||| IN
well  ||| S:969 E:974 ||| RB
as  ||| S:974 E:977 ||| IN
the  ||| S:977 E:981 ||| DT
expression  ||| S:981 E:992 ||| NN
of  ||| S:992 E:995 ||| IN
MMP‑9 ||| S:995 E:1000 ||| CD
.  ||| S:1000 E:1002 ||| .
These  ||| S:1002 E:1008 ||| DT
results  ||| S:1008 E:1016 ||| NNS
indicated  ||| S:1016 E:1026 ||| VBD
that  ||| S:1026 E:1031 ||| IN
FASN  ||| S:1031 E:1036 ||| NNP
inhibition  ||| S:1036 E:1047 ||| VBD
suppressed  ||| S:1047 E:1058 ||| VBN
the  ||| S:1058 E:1062 ||| DT
migratory  ||| S:1062 E:1072 ||| JJ
capacity  ||| S:1072 E:1081 ||| NN
of  ||| S:1081 E:1084 ||| IN
BTCC  ||| S:1084 E:1089 ||| NNP
cells  ||| S:1089 E:1095 ||| NNS
through  ||| S:1095 E:1103 ||| IN
suppressing  ||| S:1103 E:1115 ||| JJ
AKT  ||| S:1115 E:1119 ||| NNP
activation  ||| S:1119 E:1130 ||| NN
and  ||| S:1130 E:1134 ||| CC
consequently  ||| S:1134 E:1147 ||| RB
reducing  ||| S:1147 E:1156 ||| VBG
MMP‑9  ||| S:1156 E:1162 ||| CD
expression ||| S:1162 E:1172 ||| NN
.  ||| S:1172 E:1174 ||| .
Targeting  ||| S:1174 E:1184 ||| NNP
FASN  ||| S:1184 E:1189 ||| NNP
may  ||| S:1189 E:1193 ||| MD
represent  ||| S:1193 E:1203 ||| VB
a  ||| S:1203 E:1205 ||| DT
promising  ||| S:1205 E:1215 ||| JJ
novel  ||| S:1215 E:1221 ||| NN
therapeutic  ||| S:1221 E:1233 ||| JJ
strategy  ||| S:1233 E:1242 ||| NN
for  ||| S:1242 E:1246 ||| IN
BTCC ||| S:1246 E:1250 ||| NNP
.  ||| S:1250 E:1252 ||| .
